Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 33.39%69.71M | -13.79%108.96M | -0.05%52.26M | 101.29%126.39M | 50.07%52.29M | -12.13%62.79M | 11.97%34.84M | 10.32%71.46M | 38.56%31.12M | 5.26%64.78M |
| Operating income | 33.39%69.71M | -13.79%108.96M | -0.05%52.26M | 101.29%126.39M | 50.07%52.29M | -12.13%62.79M | 11.97%34.84M | 10.32%71.46M | 38.56%31.12M | 5.26%64.78M |
| Cost of sales | -48.88%-57.77M | 19.99%-81.5M | 9.04%-38.8M | -106.20%-101.86M | -49.99%-42.66M | 16.60%-49.4M | -3.34%-28.44M | -20.68%-59.24M | -47.27%-27.52M | 10.56%-49.09M |
| Operating expenses | -48.88%-57.77M | 19.99%-81.5M | 9.04%-38.8M | -106.20%-101.86M | -49.99%-42.66M | 16.60%-49.4M | -3.34%-28.44M | -20.68%-59.24M | -47.27%-27.52M | 10.56%-49.09M |
| Gross profit | -11.27%11.94M | 11.95%27.46M | 39.80%13.46M | 83.18%24.53M | 50.41%9.63M | 9.55%13.39M | 77.95%6.4M | -22.10%12.22M | -4.59%3.6M | 135.59%15.69M |
| Selling expenses | -10.57%-13.04M | -1.25%-29.05M | -20.34%-11.8M | -81.37%-28.69M | -66.70%-9.8M | -18.78%-15.82M | -25.35%-5.88M | -47.32%-13.32M | -57.47%-4.69M | 16.63%-9.04M |
| Administrative expenses | 30.81%-8.46M | -57.38%-26.41M | -46.24%-12.23M | 3.91%-16.78M | 11.95%-8.36M | 13.62%-17.46M | -22.64%-9.5M | -11.92%-20.21M | -35.40%-7.74M | 48.27%-18.06M |
| Research and development expenses | 36.13%-1.47M | -7.70%-8.05M | -1.19%-2.3M | -30.13%-7.48M | ---2.28M | 16.63%-5.75M | ---- | -2.58%-6.89M | ---- | -32.06%-6.72M |
| Impairment and provision | ---- | -4,060.66%-5.08M | ---- | -128.44%-122K | ---- | 188.27%429K | ---- | -8.48%-486K | ---- | -106.94%-448K |
| -Impairment of property, machinery and equipment | ---- | ---4.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -340.98%-538K | ---- | -128.44%-122K | ---- | 188.27%429K | ---- | -8.48%-486K | ---- | -106.94%-448K |
| Special items of operating profit | 10.60%2.2M | 66.84%2.9M | 65.28%1.99M | 9.25%1.74M | 94.19%1.2M | 123.00%1.59M | 500.00%620K | 130.38%713K | -235.96%-155K | -102.68%-2.35M |
| Operating profit | 18.81%-8.83M | -42.62%-38.22M | -13.21%-10.88M | -13.49%-26.8M | -14.99%-9.61M | 15.58%-23.61M | 7.08%-8.35M | -33.68%-27.97M | -86.81%-8.99M | 46.19%-20.92M |
| Financing income | 50.53%2.15M | -20.97%1.46M | 2,201.61%1.43M | 476.32%1.85M | 12.73%62K | 268.97%321K | -14.06%55K | -67.17%87K | -56.46%64K | -51.99%265K |
| Financing cost | -79.81%-383K | -17.04%-577K | 13.06%-213K | -92.58%-493K | -61.18%-245K | 8.24%-256K | 15.56%-152K | -96.48%-279K | -620.00%-180K | -178.43%-142K |
| Share of profits of associates | -50.00%2K | 12.50%9K | -42.86%4K | -52.94%8K | -36.36%7K | -81.32%17K | --11K | 115.17%91K | ---- | ---600K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.62M | --6.59M | ---- |
| Earning before tax | 26.87%-7.06M | -46.76%-37.33M | 1.28%-9.66M | -8.09%-25.43M | -15.90%-9.78M | -20.96%-23.53M | -235.45%-8.44M | 9.10%-19.45M | 46.37%-2.52M | 44.25%-21.4M |
| After-tax profit from continuing operations | 26.87%-7.06M | -46.76%-37.33M | 1.28%-9.66M | -8.09%-25.43M | -15.90%-9.78M | -20.96%-23.53M | -235.45%-8.44M | 9.10%-19.45M | 45.33%-2.52M | 45.19%-21.4M |
| Earning after tax | 26.87%-7.06M | -46.76%-37.33M | 1.28%-9.66M | -8.09%-25.43M | -15.90%-9.78M | -20.96%-23.53M | -235.45%-8.44M | 9.10%-19.45M | 45.33%-2.52M | 45.19%-21.4M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,818.77%-7.16M | -19,151.72%-5.53M | -136.68%-373K |
| Profit attributable to shareholders | 26.87%-7.06M | -46.76%-37.33M | 1.28%-9.66M | -8.09%-25.43M | -15.90%-9.78M | -91.37%-23.53M | -380.49%-8.44M | 41.52%-12.3M | 164.98%3.01M | 47.51%-21.03M |
| Basic earnings per share | 25.00%-0.012 | -20.00%-0.06 | 20.00%-0.016 | 0.00%-0.05 | -17.65%-0.02 | -150.00%-0.05 | -383.33%-0.017 | 50.00%-0.02 | 166.67%0.006 | 50.00%-0.04 |
| Diluted earnings per share | 25.00%-0.012 | -20.00%-0.06 | -0.016 | 0.00%-0.05 | -150.00%-0.05 | -383.33%-0.017 | 50.00%-0.02 | 166.67%0.006 | 50.00%-0.04 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | Shinaga Zhonghe (Hong Kong) Certified Public Accountants | -- | Shinaga Zhonghe (Hong Kong) Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.